With increasing demand for cell and gene therapies, mesenchymal stem cells (MSCs) have gained attention for their versatility ...

The healthcare industry has shared its concerns on a global scale after President Trump signed the executive order.

This rising trend mirrors the evolution of the pharmaceutical industry in terms of investment and utilisation of novel ...

Health Canada has granted market authorisation to Takeda Canada for FRUZAQLA capsules to treat adults with mCRC.

The EC has approved GSK's Jemperli (dostarlimab) combined with chemotherapy for primary advanced or recurrent endometrial cancer in adults.

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

Investment company RTW Investments has launched a new biotech company called Prolium Bioscience, to advance the development ...

This week, at the J.P. Morgan Healthcare Conference and the Biotech Showcase, discussions underscored the growing focus on ...

If the results from the clinical development plans are positive, it may well reflect a paradigm shift for clinical care.

An FDA approval later this year for Arrowhead’s plozasiran in FCS would put it in direct competition with Ionis’ Tryngolza.

Northwell Health’s Feinstein Institutes for Medical Research has received a $2.9m grant from the NIH to explore the use of ...